checkAd

     116  0 Kommentare Results of Tabula Rasa HealthCare’s First Simulated Clinical Study on Proposed COVID-19 Treatments and Therapies is Published - Seite 3

    TRHC Media Contact
    Amanda Bednar
    abednar@trhc.com 
    T: (856) 912-5714

    Dianne Semingson
    dsemingson@trhc.com 
    T: (215) 870-0829
    		 Investors
    Frank Sparacino
    fsparacino@trhc.com
    T: (312) 451-2157

     

    An infographic accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/39f266a5-2e22-4c29 ...


    Lesen Sie auch


    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Results of Tabula Rasa HealthCare’s First Simulated Clinical Study on Proposed COVID-19 Treatments and Therapies is Published - Seite 3 Study results demonstrate an increased risk for adverse drug events in older patients by adding COVID-19 repurposed treatments to current medication regimensMOORESTOWN, N.J., Aug. 12, 2020 (GLOBE NEWSWIRE) - Tabula Rasa HealthCare, Inc (TRHC) …